BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30842609)

  • 1. PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia.
    Bastian L; Schroeder MP; Eckert C; Schlee C; Tanchez JO; Kämpf S; Wagner DL; Schulze V; Isaakidis K; Lázaro-Navarro J; Hänzelmann S; James AR; Ekici A; Burmeister T; Schwartz S; Schrappe M; Horstmann M; Vosberg S; Krebs S; Blum H; Hecht J; Greif PA; Rieger MA; Brüggemann M; Gökbuget N; Neumann M; Baldus CD
    Leukemia; 2019 Aug; 33(8):1895-1909. PubMed ID: 30842609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IKZF1
    Stanulla M; Dagdan E; Zaliova M; Möricke A; Palmi C; Cazzaniga G; Eckert C; Te Kronnie G; Bourquin JP; Bornhauser B; Koehler R; Bartram CR; Ludwig WD; Bleckmann K; Groeneveld-Krentz S; Schewe D; Junk SV; Hinze L; Klein N; Kratz CP; Biondi A; Borkhardt A; Kulozik A; Muckenthaler MU; Basso G; Valsecchi MG; Izraeli S; Petersen BS; Franke A; Dörge P; Steinemann D; Haas OA; Panzer-Grümayer R; Cavé H; Houlston RS; Cario G; Schrappe M; Zimmermann M; ;
    J Clin Oncol; 2018 Apr; 36(12):1240-1249. PubMed ID: 29498923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation between Pax5 deletion and patients survival in Iranian children with precursor B-cell acute lymphocytic leukemia.
    Moafi A; Zojaji A; Salehi R; Najafi Dorcheh S; Rahgozar S
    Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):19-22. PubMed ID: 28886309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Genomic Landscape of PAX5, IKZF1, and CDKN2A/B Alterations in B-Cell Precursor Acute Lymphoblastic Leukemia.
    Ou Z; Sherer M; Casey J; Bakos HA; Vitullo K; Hu J; Friehling E; Gollin SM; Surti U; Yatsenko SA
    Cytogenet Genome Res; 2016; 150(3-4):242-252. PubMed ID: 28214896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocol.
    Jung M; Schieck M; Hofmann W; Tauscher M; Lentes J; Bergmann A; Stelter M; Möricke A; Alten J; Schlegelberger B; Schrappe M; Zimmermann M; Stanulla M; Cario G; Steinemann D
    Genes Chromosomes Cancer; 2020 Nov; 59(11):667-671. PubMed ID: 32592278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAX5 deletion is common and concurrently occurs with CDKN2A deletion in B-lineage acute lymphoblastic leukemia.
    Kim M; Choi JE; She CJ; Hwang SM; Shin HY; Ahn HS; Yoon SS; Kim BK; Park MH; Lee DS
    Blood Cells Mol Dis; 2011 Jun; 47(1):62-6. PubMed ID: 21549623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.
    Gu Z; Churchman ML; Roberts KG; Moore I; Zhou X; Nakitandwe J; Hagiwara K; Pelletier S; Gingras S; Berns H; Payne-Turner D; Hill A; Iacobucci I; Shi L; Pounds S; Cheng C; Pei D; Qu C; Newman S; Devidas M; Dai Y; Reshmi SC; Gastier-Foster J; Raetz EA; Borowitz MJ; Wood BL; Carroll WL; Zweidler-McKay PA; Rabin KR; Mattano LA; Maloney KW; Rambaldi A; Spinelli O; Radich JP; Minden MD; Rowe JM; Luger S; Litzow MR; Tallman MS; Racevskis J; Zhang Y; Bhatia R; Kohlschmidt J; Mrózek K; Bloomfield CD; Stock W; Kornblau S; Kantarjian HM; Konopleva M; Evans WE; Jeha S; Pui CH; Yang J; Paietta E; Downing JR; Relling MV; Zhang J; Loh ML; Hunger SP; Mullighan CG
    Nat Genet; 2019 Feb; 51(2):296-307. PubMed ID: 30643249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study.
    Coyaud E; Struski S; Prade N; Familiades J; Eichner R; Quelen C; Bousquet M; Mugneret F; Talmant P; Pages MP; Lefebvre C; Penther D; Lippert E; Nadal N; Taviaux S; Poppe B; Luquet I; Baranger L; Eclache V; Radford I; Barin C; Mozziconacci MJ; Lafage-Pochitaloff M; Antoine-Poirel H; Charrin C; Perot C; Terre C; Brousset P; Dastugue N; Broccardo C
    Blood; 2010 Apr; 115(15):3089-97. PubMed ID: 20160164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia.
    Shah S; Schrader KA; Waanders E; Timms AE; Vijai J; Miething C; Wechsler J; Yang J; Hayes J; Klein RJ; Zhang J; Wei L; Wu G; Rusch M; Nagahawatte P; Ma J; Chen SC; Song G; Cheng J; Meyers P; Bhojwani D; Jhanwar S; Maslak P; Fleisher M; Littman J; Offit L; Rau-Murthy R; Fleischut MH; Corines M; Murali R; Gao X; Manschreck C; Kitzing T; Murty VV; Raimondi S; Kuiper RP; Simons A; Schiffman JD; Onel K; Plon SE; Wheeler D; Ritter D; Ziegler DS; Tucker K; Sutton R; Chenevix-Trench G; Li J; Huntsman DG; Hansford S; Senz J; Walsh T; Lee M; Hahn CN; Roberts K; King MC; Lo SM; Levine RL; Viale A; Socci ND; Nathanson KL; Scott HS; Daly M; Lipkin SM; Lowe SW; Downing JR; Altshuler D; Sandlund JT; Horwitz MS; Mullighan CG; Offit K
    Nat Genet; 2013 Oct; 45(10):1226-1231. PubMed ID: 24013638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study.
    Familiades J; Bousquet M; Lafage-Pochitaloff M; Béné MC; Beldjord K; De Vos J; Dastugue N; Coyaud E; Struski S; Quelen C; Prade-Houdellier N; Dobbelstein S; Cayuela JM; Soulier J; Grardel N; Preudhomme C; Cavé H; Blanchet O; Lhéritier V; Delannoy A; Chalandon Y; Ifrah N; Pigneux A; Brousset P; Macintyre EA; Huguet F; Dombret H; Broccardo C; Delabesse E
    Leukemia; 2009 Nov; 23(11):1989-98. PubMed ID: 19587702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin dependent kinase inhibitor 2A/B gene deletions are markers of poor prognosis in Indian children with acute lymphoblastic leukemia.
    Agarwal M; Bakhshi S; Dwivedi SN; Kabra M; Shukla R; Seth R
    Pediatr Blood Cancer; 2018 Jun; 65(6):e27001. PubMed ID: 29446543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copy number abnormality of acute lymphoblastic leukemia cell lines based on their genetic subtypes.
    Tomoyasu C; Imamura T; Tomii T; Yano M; Asai D; Goto H; Shimada A; Sanada M; Iwamoto S; Takita J; Minegishi M; Inukai T; Sugita K; Hosoi H
    Int J Hematol; 2018 Sep; 108(3):312-318. PubMed ID: 29786757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch.
    Novakova M; Zaliova M; Fiser K; Vakrmanova B; Slamova L; Musilova A; Brüggemann M; Ritgen M; Fronkova E; Kalina T; Stary J; Winkowska L; Svec P; Kolenova A; Stuchly J; Zuna J; Trka J; Hrusak O; Mejstrikova E
    Haematologica; 2021 Aug; 106(8):2066-2075. PubMed ID: 32646889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.
    Drexler HG
    Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and clinical relevance of DNA microsatellite alterations of the CDKN2A/B, ATM and p53 gene loci: a comparison between pediatric precursor T-cell lymphoblastic lymphoma and T-cell lymphoblastic leukemia.
    Krieger D; Moericke A; Oschlies I; Zimmermann M; Schrappe M; Reiter A; Burkhardt B
    Haematologica; 2010 Jan; 95(1):158-62. PubMed ID: 19586936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer.
    An Q; Wright SL; Konn ZJ; Matheson E; Minto L; Moorman AV; Parker H; Griffiths M; Ross FM; Davies T; Hall AG; Harrison CJ; Irving JA; Strefford JC
    Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17050-4. PubMed ID: 18957548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study.
    Kim M; Yim SH; Cho NS; Kang SH; Ko DH; Oh B; Kim TY; Min HJ; She CJ; Kang HJ; Shin HY; Ahn HS; Yoon SS; Kim BK; Shin HR; Han KS; Cho HI; Lee DS
    Cancer Genet Cytogenet; 2009 Nov; 195(1):59-65. PubMed ID: 19837270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia.
    Schwab CJ; Jones LR; Morrison H; Ryan SL; Yigittop H; Schouten JP; Harrison CJ
    Genes Chromosomes Cancer; 2010 Dec; 49(12):1104-13. PubMed ID: 20815030
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Passet M; Boissel N; Sigaux F; Saillard C; Bargetzi M; Ba I; Thomas X; Graux C; Chalandon Y; Leguay T; Lengliné E; Konopacki J; Quentin S; Delabesse E; Lafage-Pochitaloff M; Pastoret C; Grardel N; Asnafi V; Lhéritier V; Soulier J; Dombret H; Clappier E;
    Blood; 2019 Jan; 133(3):280-284. PubMed ID: 30510083
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of PAX5 gene in the early stages of leukemic B cells in the childhood B cell acute lymphoblastic leukemia.
    Firtina S; Sayitoglu M; Hatirnaz O; Erbilgin Y; Oztunc C; Cinar S; Yildiz I; Celkan T; Anak S; Unuvar A; Devecioglu O; Timur C; Aydogan G; Akcay A; Atay D; Turkkan E; Karaman S; Orhaner B; Sarper N; Deniz G; Ozbek U
    Leuk Res; 2012 Jan; 36(1):87-92. PubMed ID: 21813177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.